TVTX icon

Travere Therapeutics

129 hedge funds and large institutions have $1.1B invested in Travere Therapeutics in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+10
Holders Change %
+8.4%
% of All Funds
2.96%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
21
Increased
46
Reduced
46
Closed
11
Calls
$9.96M
Puts
$1.37M
Net Calls
+$8.59M
Net Calls Change
+$949K
Name Holding Trade Value Shares
Change
Shares
Change %
AG
126
Advisor Group
Arizona
$2K -$702 -20 -26%
US Bancorp
127
US Bancorp
Minnesota
$1K +$1K +47 New
RCAG
128
Rehmann Capital Advisory Group
Michigan
$900 +$900 +33 New
GTC
129
Ghost Tree Capital
New York
-$7.03M -314,367 Closed
AC
130
Ascend Capital
California
-$5.83M -260,728 Closed
Renaissance Technologies
131
Renaissance Technologies
New York
-$3.09M -138,200 Closed
EU
132
Emory University
Georgia
-$2.57M -115,136 Closed
Arrowstreet Capital
133
Arrowstreet Capital
Massachusetts
-$2.48M -110,714 Closed
DZ Bank
134
DZ Bank
Germany
-$1.22M -54,500 Closed
ARTA
135
A.R.T. Advisors
New York
-$1M -44,870 Closed
MCM
136
Matarin Capital Management
New York
-$506K -22,632 Closed
DTL
137
Dynamic Technology Lab
Singapore
-$253K -11,323 Closed
QSS
138
Quantitative Systematic Strategies
Florida
-$245K -10,974 Closed
Group One Trading
139
Group One Trading
Illinois
-$2K -68 Closed